A Jalanko1, J Kere, E Savilahti
1Orion Corp., Orion Pharmaceutica, Biotechnology, Helsinki, Finland.
This study introduces a rapid minisequencing method for detecting genetic mutations, including the delta F508 mutation causing cystic fibrosis (CF). The technique accurately identifies specific DNA sequence alterations for improved genetic screening.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: